IL17A and chronic obstructive pulmonary disease: In COPD patients, the expression of IL-17 and IL-22 were increased in both the bronchial mucosa and lung tissue compared to healthy subjects24 Also, an increased level of IL-17A was observed with increasing GOLD stage severity and during exacerbations19,25, in induced sputum and lung biopsy tissue of COPD patients26,27.